Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma.
Sameer Farouk SaitMauricio Rendon BernotElizabeth KleinDavid H AbramsonJasmine H FrancisStephen GilheeneyMatthias A KarajannisBarbara SpitzerSuzanne L WoldenIra J DunkelNancy A KernanPublished in: Pediatric blood & cancer (2022)
OS for patients with stage 4a metastatic RB treated with ASCT with VGPR or PR to pretransplant chemotherapy was not significantly different from patients with CR. In addition, IFRT does not seem to be required for bony disease control and increased the likelihood of developing osteosarcoma.